Plasma miR-1-3p levels predict severity in hospitalized COVID-19 patients.

IF 6.8 2区医学 Q1 PHARMACOLOGY & PHARMACY

British Journal of Pharmacology Pub Date : 2024-11-21 DOI:10.1111/bph.17392

Paola Di Pietro, Angela Carmelita Abate, Carmine Izzo, Anna Laura Toni, Maria Rosaria Rusciano, Veronica Folliero, Federica Dell'Annunziata, Giovanni Granata, Valeria Visco, Benedetta Maria Motta, Alfonso Campanile, Carolina Vitale, Valeria Prete, Cristina Gatto, Giuliana Scarpati, Paolo Poggio, Gennaro Galasso, Pasquale Pagliano, Ornella Piazza, Gaetano Santulli, Gianluigi Franci, Albino Carrizzo, Carmine Vecchione, Michele Ciccarelli

引用次数: 0

查看原文本刊更多论文

血浆 miR-1-3p 水平可预测 COVID-19 住院患者的病情严重程度。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

British Journal of Pharmacology 医学-药学

CiteScore

15.40

自引率

12.30%

发文量

270

审稿时长

2.0 months

期刊介绍： The British Journal of Pharmacology (BJP) is a biomedical science journal offering comprehensive international coverage of experimental and translational pharmacology. It publishes original research, authoritative reviews, mini reviews, systematic reviews, meta-analyses, databases, letters to the Editor, and commentaries. Review articles, databases, systematic reviews, and meta-analyses are typically commissioned, but unsolicited contributions are also considered, either as standalone papers or part of themed issues. In addition to basic science research, BJP features translational pharmacology research, including proof-of-concept and early mechanistic studies in humans. While it generally does not publish first-in-man phase I studies or phase IIb, III, or IV studies, exceptions may be made under certain circumstances, particularly if results are combined with preclinical studies.